Drug Trial Radar · NCT03790111
A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer
Last checked: Nov 20, 2026Latest source record: Apr 19, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
53
Actual
Start
Mar 13, 2019
Primary completion
Jan 13, 2022
Study completion Jan 13, 2022
Sponsor
- Lead sponsor
- TerSera Therapeutics LLCIndustry
- Sponsor type
- Industry
- First posted
- Dec 31, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2, multicenter, open-label, 2-stage study to assess the safety, tolerability, and efficacy of XERMELO in combination with first-line (1L) therapy (cisplatin \[cis\] plus gemcitabine \[gem\])
Conditions
- Biliary Tract Cancer (BTC)
Interventions
telotristat ethylDrug
XERMELO (telotristat ethyl) tablets administered as 250 mg (1 x 250-mg tablet) three times a day plus first line therapy for 7 days, then XERMELO (telotristat ethyl) tablets administered as 500 mg (2 x 250-mg tablets) three times a day plus first line therapy for the duration of the study
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Progression-free Survival (PFS) as Evaluated by Central Radiologist's AssessmentTime frame: Month 6
- Project Overall Survival Rate at Month 6Time frame: 6 Months
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
TerSera Investigational Site
Gilbert, Arizona
TerSera Investigational Site
Fullerton, California
TerSera Investigational Site
Gainesville, Florida
TerSera Investigational Site
Tampa, Florida
TerSera Investigational Site
Chicago, Illinois
TerSera Investigational Site
Westwood, Kansas
TerSera Investigational Site
Lexington, Kentucky
TerSera Investigational Site
Boston, Massachusetts
TerSera Investigational Site
Grand Rapids, Michigan
TerSera Investigational Site
Buffalo, New York
TerSera Investigational Site
Lake Success, New York
TerSera Investigational Site
Charlotte, North Carolina
TerSera Investigational Site
Oklahoma City, Oklahoma
TerSera Investigational Site
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.